Sysmex America Launches FDA-Cleared XN-10 Blood Bank Mode
The Sysmex XN Blood Bank mode is intended for use in blood processing centers for QC release testing of post-processed components.
The Sysmex XN Blood Bank mode is intended for use in blood processing centers for QC release testing of post-processed components.
The PK7400 Automated Microplate System offers high throughput and is now available in countries across Europe, Canada, and the United States.
This month's Product Spotlight section features AACC exhibitors, including Helmer Scientific, Nova Biomedical, and Siemens Healthineers.
Blood bank analytics are critical both for feeding back their results to clinicians so that they can improve their transfusion prescribing practices, and for demonstrating to program executives where progress has been made.
Read MoreLines of communication between blood banks and the clinical lab, as well as with the clinical service lines in other departments, are crucial.
Read MoreIn recent years, challenges to the safety of the nation’s blood supply include a rising understanding of the risks involved in blood transfusions, threats related to known infectious diseases, and the emergence of new pathogens.
Read MoreThe program provides traditional onsite support and consulting, and predictive, connected technologies.
Read MoreThis month’s Product Spotlight features tools for hematology, blood banking, and biorepositories from such companies as Beckman Coulter, Hemo Bioscience, Ortho Clinical Diagnostics, and Sebia.
Read MoreValGenesis seeks to ensure that data created, modified, and stored within its blood banking application are capable of passing internal and regulatory audits, while improving the overall efficiency of validation programs for blood services centers.
Read MoreThe new release aims to simplify blood banking administration through improved integration with enterprise electronic health records.
Read MoreThe company reports that clinical trials using its MosaiQ transfusion diagnostic instrument and associated assays will begin later this year.
Read MoreMaking the transition from manual to automated blood analysis supports the hospital’s efforts to become a Level II trauma center.
Read MoreReasons for the blood supply’s safe levels include advances in donor screening, improved testing, automated data systems, and changes in transfusion medicine practices.
Read MoreThis month’s Product Spotlight features blood banking and biorepository tools from companies such as Beckman Coulter, Helmer, Thermo Fisher Scientific, and Wheaton.
Read MoreAn agreement between Quotient and OCD assigns MosaiQ commercialization rights in the global patient testing market and donor testing markets in the developing world and Japan, while accelerating launch of the MosaiQ system.
Read MoreNearly 5 million people in the United States receive blood transfusions each year, mainly with donations collected, separated, and stored at blood banks. These days both private and institutional blood banks and biobanks are attracting significant amounts of investment, but they’re also facing challenges.
Read MoreA panel of experts speaking at Capitol Hill recently affirmed that the US blood supply has never been safer for patients needing transfusions.
Read MoreCLP’s September 2014 Tech Guide features a range of blood banking products from vendors such as Beckman Coulter, Helmer, HemoCue America, and Sysmex America.
Read More